EP2117520
Meðferð við brjóstakrabba, sem byggist á stöðu hormónaviðtaka, með nanóögnum sem innihalda taxan
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.12.2007EP published:
29.8.2018EP application number:
07862937.5
EP translation filed:
26.11.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
13.12.2027Expiry date:
13.12.2026Next due date:
31.12.2026
Title:
BREAST CANCER THERAPY BASED ON HORMONE RECEPTOR STATUS WITH NANOPARTICLES COMPRISING TAXANE
Timeline
Today
14.12.2007EP application
29.8.2018EP Publication
26.11.2018Translation submitted
15.12.2018Registration published
13.12.2026Expires
Owner
Name:
Abraxis BioScience, LLCAddress:
86 Morris Avenue, 07901, Summit, NJ, US
Inventor
Name:
DESAI, Neil P.Address:
Pacific Palisades, CA, US
Name:
SOON-SHIONG, PatrickAddress:
Culver City, CA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
875004 PDate:
14.12.2006Country:
US
Classification
Categories:
A61K 9/51, A61K 31/337, A61K 47/42, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 20.11.2018
Expires: 13.12.2019
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 19.11.2019
Expires: 13.12.2020
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 6.11.2020
Expires: 13.12.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.11.2021
Expires: 13.12.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 9.11.2022
Expires: 13.12.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 15.11.2023
Expires: 13.12.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 5.11.2024
Expires: 13.12.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 11.12.2025
Expires: 13.12.2026
Payer: Árnason Faktor ehf.